EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel Osteoblastogenic Activity of Magnolia kobus: The Pharmacological Potential for Osteoporosis

Do Hun Lee, Ju-Hyoung Park, Dong-Wan Seo

International Journal of Molecular Sciences · 07.03.2026 · 27 (5) · 2472

DOI: 10.3390/ijms27052472 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.03.2026. Verfasst von Do Hun Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Dankook University, 119 Dandae-ro, Cheonan 31116, Republic of Korea. Hauptthemen laut MEDLINE: Magnolia, Osteoblasts, Osteoporosis, Plant Extracts. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dankook University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Magnolia kobus (M. kobus) has long been used to treat nasal congestion, allergic rhinitis, and sinusitis. In the current study, we demonstrate the effects and underlying mechanisms of M. kobus flower water extract (ME) and ME-derived constituent magnolin on in vitro osteoblastogenic and anti-osteoclastogenic responses. Treatment with ME or magnolin markedly enhanced the osteoblast differentiation and mineralization in MC3T3-E1 pre-osteoblasts. This osteoblastogenic activity of ME or magnolin was closely associated with upregulation of osteoblast-specific molecules, including RUNX2, DLX5, OSX, alkaline phosphatase, collagen type I, and osteopontin, as well as the activation of mitogen-activated protein kinase (MAPK) signaling pathways. Concurrently, magnolin inhibited osteoclast differentiation through inactivating MAPK pathways and downregulating NFATc1, c-Fos, tartrate-resistant acid phosphatase, and cathepsin K in RANKL-treated RAW264.7 cells. These observations suggest that ME and magnolin have pharmacological potential for the treatment and prevention of metabolic bone disorders, including osteoporosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MagnoliaOsteoblastsOsteoporosisPlant ExtractsOsteogenesisLignansAnimalsMiceCell DifferentiationOsteoclastsRAW 264.7 CellsRANK LigandBiphenyl CompoundsMAP Kinase Signaling System

Stichwörter der Autor:innen

MC3T3-E1Magnolia kobusanti-osteoclastogenic activitymagnolinosteoblastogenic activity

Substanzen

Plant ExtractsLignansmagnolinRANK LigandBiphenyl Compounds

Autor:innen und Institutionen

  • College of Pharmacy, Dankook University, 119 Dandae-ro, Cheonan 31116, Republic of Korea.
  • Center for Human Risk Assessment, Dankook University, 119 Dandae-ro, Cheonan 31116, Republic of Korea.

Förderung

  • Dankook University

Zitieren

APA

Lee, D. H., Park, J. H., & Seo, D. W. (2026). Novel Osteoblastogenic Activity of Magnolia kobus: The Pharmacological Potential for Osteoporosis. International Journal of Molecular Sciences, 27(5), 2472. https://doi.org/10.3390/ijms27052472

Vancouver

Lee DH, Park JH, Seo DW. Novel Osteoblastogenic Activity of Magnolia kobus: The Pharmacological Potential for Osteoporosis. International Journal of Molecular Sciences. 2026;27(5):2472. doi:10.3390/ijms27052472

BibTeX
@article{Lee2026,
  author = {Lee, Do Hun and Park, Ju-Hyoung and Seo, Dong-Wan},
  title = {Novel Osteoblastogenic Activity of Magnolia kobus: The Pharmacological Potential for Osteoporosis},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {5},
  pages = {2472},
  doi = {10.3390/ijms27052472}
}
Kostenlos starten →